To. Frommel et al., EFFECT OF ASPIRIN ON PROSTAGLANDIN E-2 AND LEUKOTRIENE B-4 PRODUCTIONIN HUMAN COLONIC MUCOSA FROM CANCER-PATIENTS, Clinical cancer research, 3(2), 1997, pp. 209-213
Results from epidemiological studies indicate that chronic administrat
ion of aspirin reduces the incidence of colon cancer, The mechanism th
at accounts for this reduction is not known, but it may be related to
the decreased production of prostanoids that results from aspirin inhi
bition of cyclooxygenase. However, it is not known whether aspirin has
a local effect on prostanoid production in the colonic mucosa and whe
ther this effect is dose dependent, In this study, we determined the e
ffect of oral administration of aspirin on the production of the prost
anoid prostaglandin E-2 (PGE(2)) in the intact human colonic mucosa, I
nhibition of cyclooxygenase could result in an increased availability
of arachidonic acid and a corresponding increase in production of othe
r eicosanoids. To determine whether such an effect occurs, we also qua
ntitated the concentration of leukotriene B-4 (LTB4) in colonic mucosa
l samples. Mucosal samples were obtained during sigmoidoscopy from the
colons of 17 subjects with a history of colonic cancer prior to and f
ollowing 60 days of self-administration of 325 mg aspirin/day and agai
n 60 days after administration of 650 mg aspirin/day, PGE(2) and LTB4
concentrations were determined by enzyme immunoassay for tissue sample
s that were flash frozen after removal from the biopsy forceps and als
o in medium that was collected from tissue samples that were incubated
for 4 h following removal from the subject, PGE(2) concentrations wer
e decreased significantly in samples collected after 60 days of consum
ption of 325 mg aspirin. An additional 60 days of consuming 650 mg asp
irin/day did not result in a further significant decrease relative to
that attained after consumption of 325 mg/day. Similar results were ob
tained using colonic explants, and the addition of aspirin to medium f
urther reduced PGE(2) production, LTB4 in tissue and medium was not si
gnificantly different in pre-versus post-aspirin samples, with the exc
eption of an increased concentration in medium samples collected after
consumption of 650 mg/day relative to pre-aspirin samples, The result
s indicate that aspirin affects eicosanoid production in the colonic m
ucosa of humans, but the effect is most likely restricted to products
of the cyclooxygenase-dependent pathway. It appears that 325 mg of asp
irin is sufficient to affect PGE(2) production and that increasing the
dosage to 650 mg daily provides an additional decrease in PGE(2) synt
hesis. However, the higher dosage was associated with a considerable i
ncrease in complaints of gastric discomfort. Additional study is neede
d to establish whether doses less than 325 mg also provide a significa
nt decrease in PGE(2) production.